<html>
<head>
    <meta name="GENERATOR" content="Microsoft Visual Studio 6.0">
    <title>Biological Use Authorization</title>
    <!-- <link rel="stylesheet" type="text/css" href="/appAsp/Include/ORA1.css"> -->
    <!-- <link rel="stylesheet" type="text/css" href="/appAsp/Include/Ora_BlueTables.css"> -->
    <link rel="stylesheet" type="text/css" href="/OrPortal/Forms/Compliance/IBC/IBC.css">
    <!-- Get Database Subroutines -->
    
    <!-- End Get Database Subroutines -->
    <!-- #XXXinclude virtual = "/appAsp/Include/StringUtilities.asp" -->
    
    <style>
.OriginalValuesBorder {
    border:3px solid orange;margin-top:5px;
}
.OriginalValuesTitle {
    color:orange;
    font-weight:bold;
}
.highlight {
    background-color:lightyellow; 
    border:1px solid orange;
    padding:2px;
}
.SemiHighlight {
    color:orange;
}
.warning {
    background-color:#FFE4C4; 
    border:1px solid orange;
    padding:2px;
}

th, .thBlue	{
	text-align:left;
	vertical-align:top;
	font-size:8pt;
	font-weight:bold;
	font-family:verdana;
}
td, .tdBlue	{
	text-align:left;
	vertical-align:top;
	font-size:8pt;
	font-family:verdana;
}

.THLine1 {
	color:navy;
	background:#F5F5F5;
	font-size:8pt;
	font-weight:bold;
}
.TDLine1 {
	color:navy;
	background:#F5F5F5;
	font-size:8pt;
}

.THLine2 {
	color:navy;
	background:white;
	font-size:8pt;
	font-weight:bold;
}
.TDLine2 {
	color:navy;
	background:white
	font-size:8pt;
}


.GlobalTd {
	background:white;
	color:navy;
	font-size:9pt;
}
.hdg1 {
	background:white;
	color:navy;
	font-size:12pt;
	font-weight:bold;
}
.xxxhdg2 {
	background:white;
	color:brown;
	font-size:11pt;
	font-weight:bold;
}
.hdg2 {
	background:navy;
	color:white;
	font-size:11pt;
	font-weight:bold;
	margin:1px;
	border-width:1px;
	border-color:white;
	padding:2px;
}
.hdg3 {
	background:white;
	color:navy;
	font-size:12pt;
	font-weight:bold;
}


</style>
    <script>window.status='ORA Production Database';</script>
</head>
<body>
    <form action method="POST" id="form1" name="form1">
        <!-- Outer Table -->
        <table width="650" cellpadding="2" cellspacting="0" border="1">
            <tr>
                <td class="GlobalTd">
                    <script>window.status='ORA Production Database';</script><table width="100%" cellpadding="0" cellspacing="0" border="0px"><tr>
<td>Protocol#: B-20180035-01 (Amendment)</td>
<td style="text-align:right;">
<input type="checkbox" name="Compare">Compare with Original&#160;<input type="submit" name="Refresh" value="Go">
</td>
</tr></table>
<br><br><div class="hdg1" align="center">University of California, Riverside<br>Institutional Biosafety Committee (IBC)<br>Application for Biological Use Authorization Registration</div>
<br><div class="hdg2">A. INVESTIGATOR DATA</div>
<table border="0" cellpadding="1" cellspacing="1" width="100%">
<tr>   <th class="THBlue">Principal Investigator</th>   <td class="TDBlue">Peter William Atkinson</td>
<td rowspan="10">&#160;&#160;&#160;&#160;&#160;</td>   <th class="THBlue">Email</th>   <td class="TDBlue">peter.atkinson@ucr.edu</td>
</tr>
<tr>   <th class="THBlue">Department</th>   <td class="TDBlue">Entomology</td>   <th class="THBlue">Phone</th>   <td class="TDBlue">(951) 827-4782</td>
</tr>
<tr>   <th class="THBlue">Project Start/End Date</th>   <td class="TDBlue">9/1/2018-8/31/2021</td>   <th class="THBlue">Fax</th>   <td class="TDBlue">(951) 827-3086</td>
</tr>
<tr>   <th class="THBlue" colspan="5">
<br>Project Title:</th>
</tr>
<tr>   <td class="TDBlue" colspan="5"> Fine-Scale Recombination Rate Variation in Anopheles gambiae (NIAID), Gene Editing in Plutella xylostella (BASF/CARA), SW Vector-Borne Disease Regional Center of Excellence (CDC), 
Immune priming the piRNA pathway for arboviral resistance in Aedes aegypti (NIAID),  Establishing a CRISPR-based gene drive system for controlling the haplodiploid agricultural pest, the whitefly B. tabaci (BARD to LL Walling and PWA), Genome Edited Whiteflies for the Future of Agriculture (DARPA to LLW/PWA)</td>
</tr>
<tr>   <th class="THBlue" colspan="5">
<br>Related Funding Agency(ies) (add as many as apply, even if use of rDNA is identical for each project):</th>
</tr>
<tr>   <td class="TDBlue" colspan="5">National Institutes of Health, National Science Foundation/BARD, Centers for Disease Control, BASF, California Department of Agriculture, WM Keck Foundation.</td>
</tr>
<tr><td colspan="5">&#160;</td></tr>
<tr>   <th class="THBlue" colspan="2">Additional Contact person and phone # (if not or in addition to the PI):</th>   <td class="TDBlue" colspan="2"></td>
</tr>
</table>
<br><br><div class="hdg2">B. RESEARCH LOCATIONS</div>
<table border="1" width="100%" cellpadding="1" cellspacing="0">
<tr>   <th class="THBlue" width="15%">Building &#160;&#160;&#160;</th>   <th class="THBlue" width="15%">Room #  &#160;&#160;&#160;</th>   <th class="THBlue" width="55%">List any containment facilities or equipment (biosafety cabinets, etc.) and their last certification dates. &#160;&#160;&#160;</th>   <th class="THBlue" width="15%">Certification<br>Date</th>
</tr>
<tr>   <td class="TDBlue">AgOps Greenhouse &#160;&#160;&#160;</td>   <td class="TDBlue">16-56&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Genomics&#160;&#160;&#160;</td>   <td class="TDBlue">2237, 2231/A, 2233/A, 2235&#160;&#160;&#160;</td>   <td class="TDBlue">Biosafety cabinets, chemical hoods, ACL2 insectary&#160;&#160;&#160;</td>   <td class="TDBlue">8/3/2018&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">IQF&#160;&#160;&#160;</td>   <td class="TDBlue">226, 234, 236, 238&#160;&#160;&#160;</td>   <td class="TDBlue">Secondary screens placed on doors of 234, 236 and  238.  &#160;&#160;&#160;</td>   <td class="TDBlue">8/8/2019&#160;&#160;&#160;</td>
</tr>
</table>
<br><br><div class="hdg2">C. PRIOR APPROVAL STATUS</div>
<table border="0" cellpadding="7" cellspacing="0">
<tr>   <th width="50%" class="THBlue">Application Type</th>   <td width="50%" class="TDBlue">Renewal</td>
</tr>
<tr>   <th class="THBlue">If &#8220;Yes&#8221;, please list the number of the approved protocol</th>   <td class="TDBlue">BUA20120019</td>
</tr>
<tr>   <th class="THBlue">Does this project involve human or animal subjects, or a positive disclosure of a conflict of interest (income, loans, or management role in funding source, etc.)?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;Yes&#8221;, has this project been reviewed by any other UCR review boards?  If so, indicate the relevant protocol numbers and approval dates:</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">IRB (human subjects)</th>   <td class="TDBlue">N/A</td>
</tr>
<tr>   <th class="THBlue">IACUC (animal subjects)</th>   <td class="TDBlue">N/A</td>
</tr>
<tr>   <th class="THBlue">Conflict of interest (provide approval date)</th>   <td class="TDBlue">N/A</td>
</tr>
<tr>   <th class="THBlue">Does this project involve strains of plant or animal pathogens not originating in California?</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">If &#8220;Yes&#8221;, CDFA and APHIS permits may be required.  List the relevant permit numbers and dates covered:</th>
</tr>
<tr>   <th class="THBlue">CDFA</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">APHIS</th>   <td class="TDBlue">P526P-170621-013, P526-171130-013</td>
</tr>
<tr>   <th class="THBlue">Do experiments involve releasing organisms containing rDNA into the environment?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;Yes&#8221;, has an application for this release been filed with a state or federal regulatory agency?	Agency and date filed:</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Will you be using  a "Select Agent" (<a href="http://www.cdc.gov/od/ohs/lrsat.htm">www.cdc.gov/od/ohs/lrsat.htm</a>)</th>   <td class="TDBlue">False</td>
</tr>
</table>
<br><br><div class="hdg2">DESCRIPTION OF PROJECT</div>
<table border="0" cellpadding="7" cellspacing="0">
<tr>   <th class="THBlue">Provide a brief, non-technical description and purpose of the project.</th>
</tr>
<tr>   <td class="TDBlue">The amendment notes the relocation of mosquitoes from 135 to 236 and 238 and the use of 234 for whiteflies.  We undertake research aimed at developing genetic and chemical based insect pest control strategies for medically and agriculturally important insect species.  The mosquito species we focus on are the yellow fever mosquito Aedes aegypti, the southern house mosquito, Culex pipiens quinquefasciatus, the African malaria mosquito Anopheles coluzzii, and the southern asian malaria mosquito Anopheles stephensi. Our approaches are to develop gene tagging strategies that identify genes expressed in tissues involved in pathogen transmission and to explore how a small RNA pathway in Aedes and Culex provides immunity to pathogenic mosquito viruses.  Our aim here is to harness this response so it provides mosquitoes immunity to human pathogenic viruses transmitted by mosquitoes.   For Lepidoptera we develop mutants with easily scored phenotypes.  In addition we use CRISPR mutagenesis to explore some aspects of insecticide resistance.  For the Hemiptera we are developing genetic methods in order to identify genetic and biochemical pathways that will form the basis of new pest control strategies.  </td>
</tr>
<tr>   <th class="THBlue">What are the specific objectives of the work with biohazardous materials?</th>
</tr>
<tr>   <td class="TDBlue">We seek to genetically alter pest insect species in order to control them and the damage they exact upon human welfare either through vectoring human pathogens or by negatively impacting agriculture.  To do this we employ transpositional recombination, site-specific recombination and CRISPR/Cas-mediated genome editing, each of which can generate genetically modified insects.  Specifically, weseek to develop mosquitoes that are incapable of transmitting human disease.  To do this we need to develop genetic strategies for mosquitoes that can deliver suitable genes that can  then spread through mosquito populations.  We seek to develop Lepidoptera pests that are tagged with new and novel screenable genetic markers and have desired mutations in genes involved in insecticide resistance and in host plant feeding.  We seek to develop Hemiptera pests that: are tagged with new and novel screenable genetic markers; have mutations which affect their ability to feed on planet hosts; are modified to replace wild type populations and in doing so replace field populations with populations carrying desired traits.   All approaches with all of the species we study also increase our knowledge of basic science underpinning how these species maintain their pestiferous properties.</td>
</tr>
</table>
<br><br><div class="hdg2">Potentially Biohazadous Materials</div>Please indicate yes or no if the following biohazardous materials are used currently within your laboratory or are proposed with the next year.  Please check all that apply.<table width="100%" border="0" cellpadding="0" cellspacing="0">
<tr>   <th colspan="2"><span class="hdg3">Human or Animal Infectious Agents</span></th>
</tr>
<tr>   <th class="THLine1">Viruses</th>   <td class="TDLine1">True</td>
</tr>
<tr>   <th class="THLine2">Bacteria</th>   <td class="TDLine2">True</td>
</tr>
<tr>   <th class="THLine1">Fungi</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Prions</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Other</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th colspan="2">
<br><span class="hdg3">Plant Infectious Agents</span>
</th>
</tr>
<tr>   <th class="THLine1">Viruses</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Bacteria</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Fungi</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Other</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th colspan="2">
<br><span class="hdg3">Recombinant DNA</span>
</th>
</tr>
<tr>   <th class="THLine1">Recombinant DNA in any form.</th>   <td class="TDLine1">True</td>
</tr>
<tr>   <th class="THLine2">Intentional release to the environment</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Other</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th colspan="2">
<br><span class="hdg3">Transgenic Plants</span>
</th>
</tr>
<tr>   <th class="THLine1">Plants</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Liverworts</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Mosses</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Algae</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Other</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th colspan="2">
<br><span class="hdg3">Animals</span>
</th>
</tr>
<tr>   <th class="THLine1">Animals that are potential reservoirs of zoonotic diseases<br>(primates, wild animals, etc.)</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Infectious or hazardous agents in animals</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Human or primate cells in animals</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Transgenic animals</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Other</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th colspan="2">
<br><span class="hdg3">Invertebrates</span>
</th>
</tr>
<tr>   <th class="THLine1">Exotic Arthropods</th>   <td class="TDLine1">True</td>
</tr>
<tr>   <th class="THLine2">Nematodes</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Intentional release to the environment</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Transgenic Insects</th>   <td class="TDLine2">True</td>
</tr>
<tr>   <th class="THLine1">Other</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th colspan="2">
<br><span class="hdg3">Human Stem Cells</span>
</th>
</tr>
<tr>   <th class="THLine1">Human Stem Cells</th>   <td class="TDLine1">False</td>
</tr>
</table>
<br><div class="hdg2">Human or Animal Infectious Agents</div>
<table width="100%" border="1" cellpadding="1" cellspacing="0">
<tr>   <th class="THBlue">List of Agents &#160;&#160;&#160;</th>   <th class="THBlue">Host of Range of Agent &#160;&#160;&#160;</th>
</tr>
<tr>   <td class="TDBlue">Transposable elements&#160;&#160;&#160;</td>   <td class="TDBlue">Insects, human cells, yeast&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Dengue virus&#160;&#160;&#160;</td>   <td class="TDBlue">Humans, mosquitoes&#160;&#160;&#160;</td>
</tr>
</table>
<table border="0" cellpadding="7" cellspacing="0">
<tr>   <th width="50%" class="THBlue">Are you using the wild-type of the agent?</th>   <td width="50%" class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">Are you using genetically modified infectious agents (rDNA, mutagenesis, etc.)?</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes,&#8221; please describe the agent and any potential safety issues.</th>   <td class="TDBlue">We seek to develop hyperactive forms of these transposable elements using both targeted and random mutagenesis, followed by testing in bacteria and/or fungi, and then in the insect.  For dengue we will procure the virus from the CDC MR4 collection</td>
</tr>
<tr>   <th class="THBlue">Do the experiments have the potential to increase the host range of the agent?</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">Is the vector replication competent?</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">Are you using fusion proteins or cell entry domains?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes,&#8221; please describe any safety precautions you would recommend.</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Are you using human or primate blood, blood products, cells, cell lines or tissues</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">If &#147;yes,&#148; please describe the blood, blood products, cells, cell lines or tissue and detail how the sample will be worked with during experimentation. Please include vendor information such as the ATCC number if available.</th>   <td class="TDBlue">The mosquitoes are fed on bovine blood using a membrane feeder. The blood is obtained from a commercial supplier.</td>
</tr>
</table>
<br><div class="hdg2">Recombinant DNA</div>
<table width="100%" border="1" cellpadding="1" cellspacing="0">
<tr>   <th class="THBlue">General features of the DNA &#160;&#160;&#160;</th>   <th class="THBlue">Species from which DNA originated &#160;&#160;&#160;</th>   <th class="THBlue">Species to receive DNA, type of vector, and transformation method &#160;&#160;&#160;</th>
</tr>
<tr>   <td class="TDBlue">cDNA, genomic DNA, viral DNA, structural genes and their promoters, 5'UTRs, 3'UTRs, recombinase genes, small RNAs.&#160;&#160;&#160;</td>   <td class="TDBlue">Drosophila melanogaster, D. mauritiana, Trichoplusia ni, Aedes aegypti, Anopheles gambiae, Anopheles stephensi, Escherichia coli, Saccharomyces cervisiaie, Aequuorea victoria, Myotis, Culex pipiens qu&#160;&#160;&#160;</td>   <td class="TDBlue">D. melanogater, Ae. aegypti, An. gambiae, An. stephensi, Cx. p. quinquefascaitus, E. coli, S. cerevisiae, Homo sapiens.&#160;&#160;&#160;</td>
</tr>
</table>
<table border="0" cellpadding="7" cellspacing="0">
<tr>   <th width="50%" class="THBlue">Will cultures of any recombinant organisms listed above exceed a volume of 10 liters?  </th>   <td width="50%" class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If so, where will the cultures be grown?</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Does your experiment involve the transfer of a drug resistance trait to any microorganism, plant, or insect that does not acquire that trait naturally?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes&#8221;, describe any potential environmental or health hazards of the experiments, including whether acquiring such a trait would compromise the use of the drug in medicine or agriculture.</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Are you expressing genes encoding toxins with LD 50 less that 10 ng/kg of body weight?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes&#8221;, describe the toxic product and safety precautions.</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Are you using hosts or vectors of rDNA (excluding E. coli K-12) that are viable pathogens of animals, plants, or microbes?</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes&#8221;, describe any potential environmental or health hazards, containment precautions, and disposal protocols.</th>   <td class="TDBlue">Bacillus subtilis  - will be disposed of using BSL-2 procedures</td>
</tr>
<tr>   <th class="THBlue">Are you using recombinant DNA molecules containing the partial genome of any eukaryotic (plant or animal) virus?</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes&#8221;, describe the molecules, including genetic maps and the fraction of virus genome present, and safety precautions.</th>   <td class="TDBlue">The SV40 3' UTR</td>
</tr>
<tr>   <th class="THBlue">Are your experiments likely to enhance the pathogenicity or extend the host range of a viral vector (e.g., introduction of novel control elements or a oncogene)?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes&#8221;, describe the hazards and safety precautions.</th>   <td class="TDBlue">NOT a viral vector, but it does have the potential to alter the host range of a transposable element.</td>
</tr>
<tr>   <th class="THBlue">Will you be using genes involved in cell cycle control in animals (oncogene, tumor suppressor, cytokine, etc.)?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes&#8221;, describe the potential hazards.</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Medical surveillance requirements or practices that you would recommend (antibody titering, etc.)?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes&#8221;, list your recommendations in section 5.</th>   <td class="TDBlue"></td>
</tr>
</table>
<br><div class="hdg2">Invertebrates</div>
<table width="100%" border="1" cellpadding="1" cellspacing="0">
<tr>   <th class="THBlue">List of Invertebrates &#160;&#160;&#160;</th>   <th class="THBlue">Range of Invertebrates &#160;&#160;&#160;</th>   <th class="THBlue">Exotic &#160;&#160;&#160;</th>
</tr>
<tr>   <td class="TDBlue">D. melanogaster, Ae. aegypti, An. gambiae (A. coluzzii), Cx. p. quinquefasciatus, An. stephensi, B. tabaci, S. frugiperda, P. xylostella, H.&#160;&#160;&#160;</td>   <td class="TDBlue">Orders diptera, Lepidoptera, Hemiptera&#160;&#160;&#160;</td>   <td class="TDBlue">I have import permits from APHIS for P. xylostealla and S. frugiperda although both exist in California.  A, gambiae/coluzzii and A. stephensi do not exist in California.&#160;&#160;&#160;</td>
</tr>
</table>
<table border="0" width="100%" cellpadding="7" cellspacing="0">
<tr>   <th width="50%" class="THBlue">Is the organism an arthropod?</th>   <td width="50%" class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">Does the arthropod belong to one of the following categories: D. melanogaster, Coleoptera, Lepidoptera, cockroaches and was purchased locally or collected from local populations?</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">Does the arthropod transmit pathogens of public health importance?</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes,&#8221; then please list which ones.</th>   <td class="TDBlue">Anopheles:  Plasmodium falciparum and vivax;  Aedes: Dengue, Zika; Culex: West Nile Viruses and a range of viruses that cause fever and/or encephalitis in humans and livestock.</td>
</tr>
<tr>   <th class="THBlue">Is the arthropod regulated by USDA or USFWS?</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes,&#8221; please list any permits.</th>   <td class="TDBlue">APHIS P526P-170621-013, P526-171130-013 for P. xylostella and S frugiperda</td>
</tr>
<tr>   <th class="THBlue">If the arthropod escaped would it be inviable or transient?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">Is there active vector borne disease cycling?</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">Is the arthropod itself genetically engineered or does it now contain an engineered virus or endosymbiont.</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">Does the arthropod contain an engineered foreign, autonomous transposable element?</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">Are the mobility properties of the transposable element known?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">Can the transposable element spread through the species?</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">Suggested level of biological containment.</th>   <td class="TDBlue">
<img src="/appAsp/images/CheckBox.gif">ACL1 &#160;&#160;&#160;<img src="/appAsp/images/CheckedBox.gif">ACL2 &#160;&#160;&#160;<img src="/appAsp/images/CheckedBox.gif">ACL3 &#160;&#160;&#160;</td>
</tr>
</table>
<br><br><div class="hdg2">Define Controls</div>
<table border="0" cellpadding="7" cellspacing="0">
<tr>   <th class="THBlue" width="50%">Do you need special equipment, engineering safeguards or personal protective equipment to maintain containment of your experiments (hoods, negative pressure rooms, gloves, etc.) </th>   <td class="TDBlue" width="50%">True</td>
</tr>
<tr>   <th class="THBlue"> If &#8220;yes&#8221;, list your recommendations.</th>   <td class="TDBlue">We will obtain the DENV2 Jamaica strain of dengue from either the CDC MR4 facility or from colleagues in the US who have cultured it.  We will culture this in Aedes albopictus cell culture under BSL2 conditions in my lab in 2237 Genomics and then prepare viral extracts for infection of Aedes aegypti mosquitoes through blood feeding of infected bovine blood.   This infection, rearing and analysis of infected mosquitoes  will be performed under ACL3 conditions in the IQF.  Infected and control mosquitoes will be reared inside perspex cages with mesh and sleeves.  This ACL3 insectary suite will be renovated in 2018/19.

In separate experiments dealing the whitefly Bemisia tabaci, genetically edited whitefly that contain gene drive systems will be reared in the new ACL3 suite, specifically in cages in the greenhouse attached to it.  These strains will be created in the Atkinson laboratory in 2237 Genomics and reared as immobile nymphs in the ACL2 insectary within it.  They will be transported in double sealed plastic containers to the IQF before emergence.</td>
</tr>
<tr>   <th class="THBlue">Medical surveillance requirements or practices that you would recommend (antibody titering, etc.)? </th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Suggested level of biological containment.</th>   <td class="TDBlue">BSL2</td>
</tr>
</table>
<br><div class="hdg2">Acknowledgement of Responsibilities</div>
<div class="tdBlue">For each of the elements below, please indicate if you will be following the UCR standard operating procedures and/or policies. If you indicate &#8220;yes&#8221; then you agree to and must follow the standard procedures and/or policies. If you answer &#8220;no,&#8221; please enter a brief description (in the space provided below the question) of the procedure you will follow and include a justification for deviating from the standard procedure and/or policy.</div>
<table border="0" width="100%" cellpadding="7" cellspacing="0">
<tr>   <th class="THBlue">Decontamination of biohazardous spills: I will used a 0.5 % sodium hypochlorite  (1:10 dilution of household bleach) to decontaminate equipment and work surfaces.  In locations where bleach would cause corrosion, I will decontaminate with an iodophor (e.g., Wescodyne).</th>   <td class="TDBlue" nowrap>True</td>
</tr>
<tr>   <td colspan="2" class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Storage: Biohazardous material will be clearly labeled with the universal biohazard symbol.</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <td colspan="2" class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">If I am using human or non-human primate blood or blood products, unfixed tissue, bodily fluids or organ or cell cultures of human origin, I will follow the exposure control plan for bloodborne pathogens.</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <td colspan="2" class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">All injuries and accidental inoculation, ingestion or inhalation of biohazardous material will be reported immediately to the lab director or supervisor and EH&amp;S (827-2648).  Dial 911 immediately for any medical emergency.</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <td colspan="2" class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">All shipments of biological materials will follow university policy and all applicable federal and international regulations whenever shipped domestically or internationally.  Proper importation or exportation permits and licenses will be obtained before shipping or reviving biological materials to or from any international location.</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <td colspan="2" class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">If I am generating medical and/or biohazardous waste, I will abide by the UC Riverside Medical and/or Biological waste plans.</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <td colspan="2" class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">I understand that UC Riverside may be required by law to release a copy of this application to the public.</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">I understand that failure to comply with the applicable regulations governing the use of biohazardous materials described above may result in suspension of the authorization and might jeopardize any funding supporting the activities described herein.</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">I attest that I will conduct the study identified above in the manner described.  If I decide to make any changes in the procedure or if any problems occur which involve risk or the possibility of risk to others, I will immediately report such occurances or contemplated changes to the UCR Institutional Biosafety Committee, Research and Economic Development, 200 University Office Building, ext 2-4809; IBC@ucr.edu.</th>   <td class="TDBlue">True</td>
</tr>
</table>
<br><table border="0" width="100%" cellpadding="0" cellspacing="0">
<tr>
<td>______________________________</td>
<td>___________</td>
<td rowspan="2">&#160;&#160;&#160;&#160;</td>
<td>______________________________</td>
<td>___________</td>
</tr>
<tr>
<td>Principal Investigator</td>
<td>Date</td>
<td>Co-Investigator</td>
<td>Date</td>
</tr>
</table>
<br><em>Electronically signed and submitted to ORA on 8/13/2019 9:54:51 AM by <b>Peter Atkinson</b></em><hr>IBC CERTIFICATION<div class="tdBlue">I certify that the Institutional Biosafety Committee has reviewed the proposed project.  In compliance with NIH guidelines and other specific NIH instructions, the project is (check one)<br><img src="/appAsp/images/CheckedBox.gif"> Approved as is.<br><img src="/appAsp/images/CheckBox.gif"> Approved with the following conditions:<br><em>This is my own amendment application.  I have a COI here.</em><br><br><br>
</div>
<table border="0" width="100%" cellpadding="0" cellspacing="0">
<tr>
<td>Level:	<img src="/appAsp/images/CheckBox.gif">BL1 &#160;&#160;<img src="/appAsp/images/CheckedBox.gif">BL2 &#160;&#160;<img src="/appAsp/images/CheckBox.gif">BL3 &#160;&#160;<img src="/appAsp/images/CheckBox.gif">BL4 &#160;&#160;</td>
<td>
<em>Electronically Signed by<br><u><b>Ayala Rao</b></u></em> _______________________________9/5/2019</td>
</tr>
<tr>
<td>&#160;</td>
<td>Chair-Institutional Biosafety Committee &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Date</td>
</tr>
</table>
                    <!-- End Outer Table -->
                </td>
            </tr>
        </table>
    </form>
</body>
</html>
